ReviewActa epileptologica2026
Trends in the studies of pharmacoresistant epilepsy- a review based on literature analysis (2015-2025).
Review in Acta epileptologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Drug-resistant epilepsy (DRE) is a complex neurological disease that accounts for 30%-40% of all epilepsy cases. Its pathogenesis and treatment have always been research hotspots in this field. In recent years, interdisciplinary research on DRE has gradually become a hot topic owing to the research and application of gene sequencing, neuroimaging, new antiepileptic therapies, and artificial intelligence. To reveal the knowledge structure and research trends in this field, this study conducted a bibliometric analysis based on the literature from 2015 to 2025 in the PubMed database, utilizing tools such as R-bibliometrix and CiteSpace to reveal the research trends, core authors, hot topics, and future directions in the DRE field. The analysis showed that from the sorted documents, Professor Bartolomei Fabrice is the most productive author and has published 80 articles on drug-resistant epilepsy. The Capital Medical University of China was the most active institution. The USA, China, and Italy are the countries with the most research contributions, accounting for 25.67%, 15.71%, and 8.09%, respectively. Through keyword analysis and theme evolution, hotspots (such as the ketogenic diet and cannabidiol) and trends (the shift from anti-seizure medications to new therapies) in drug-resistant epilepsy research were explored, revealing dynamic changes in research directions in the field, and that the DRE field is experiencing a paradigm shift from empirical treatment to precision medicine. Robot and artificial intelligence-assisted diagnosis and treatment may become important research directions in the future. This literature analysis study may provide an overview of the research field and references for future research directions in the DRE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.